Skip to main content
. 2022 Nov 29;76(8):1476–1482. doi: 10.1093/cid/ciac916

Figure 1.

Figure 1.

Various spike protein mutations associated with resistance identified following receipt of sotrovimab in 11 patients, including 8 hospitalized cases and 2 persistent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections. *Patient had a coronavirus disease 2019–related hospitalization after receipt of sotrovimab. ‡Patient had a persistent SARS-CoV-2 infection.